It’s May Awareness Month, and Dr. Dave Stukus and Allergic Living’s Gwen Smith sit down for an illuminating conversation on food allergies and asthma.
In this video, they cover a range of issues, including:
- The newly approved biologic food allergy therapy (omalizumab).
- Who’s a candidate for the treatment, plus other therapy options.
- Progress on novel epinephrine nasal sprays and film.
- How to get past auto-injector hesitation with your child.
- Why pollen allergies are so much worse (and what you can do).
- With asthma, good news on inhaler price caps; bad news on access.
- What to do if there’s wildfire smoke and you have asthma.
- They end on Dr. Dave’s allergy myth-busters.
On the new and emerging food allergy therapies, Dr. Stukus says: “It’s fantastic that we have realistic viable treatment options.” If you haven’t been to your allergist lately to hear about, he counsels: “Please make an appointment. Things are changing!”
This video discussion was co-hosted by the American Academy of Allergy, Asthma & Immunology (@AAAAI_org) and Allergic Living. Dr. David Stukus, Director of the Food Allergy Treatment Center at Nationwide Children’s Hospital in Columbus, Ohio, is AAAAI’s social media director.
Articles Referenced in Video:
Biologic for Food Allergies: Study Unveiled to Allergists
4 Epinephrine Auto-Injector Alternatives
Why Climate Change is Making Pollen Allergies Worse Than Ever
